(Q39309007)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28508231%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

review article

1 reference

title

Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28508231%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

corrigendum / erratum

Erratum to: Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target.

0 references

author

Stephen Safe

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28508231%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Siva Kumar Kolluri

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28508231%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Un-Ho Jin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28508231%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

15 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28508231%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

published in

Archives of Toxicology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28508231%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28508231%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28508231%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

2497-2513

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28508231%20AND%20SRC:MED&resulttype=core&format=json

Insights into Orphan Nuclear Receptors as Prognostic Markers and Novel Therapeutic Targets for Breast Cancer

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Emerging roles of orphan nuclear receptors in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Enzalutamide: Development from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

2,3,7,8-Tetrachlorodibenzo-p-dioxin blocks androgen-dependent cell proliferation of LNCaP cells through modulation of pRB phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

From dioxin toxicity to putative physiologic functions of the human Ah receptor in homeostasis of stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Multidisciplinary management of hepatocellular carcinoma in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Activation of the aryl hydrocarbon receptor AhR Promotes retinoic acid-induced differentiation of myeloblastic leukemia cells by restricting expression of the stem cell transcription factor Oct4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Nuclear receptors and their selective pharmacologic modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor activation in hematopoietic stem/progenitor cells alters cell function and pathway-specific gene modulation reflecting changes in cellular trafficking and migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up-regulation and cell growth in human lung adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor protects lung adenocarcinoma cells against cigarette sidestream smoke particulates-induced oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Tryptophan derivatives regulate the transcription of Oct4 in stem-like cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Up-regulation of osteopontin expression by aryl hydrocarbon receptor via both ligand-dependent and ligand-independent pathways in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Mortality rates among trichlorophenol workers with exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The dioxin receptor has tumor suppressor activity in melanoma growth and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The aryl hydrocarbon receptor contributes to the proliferation of human medulloblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Molecular expression analysis of beta-naphthoflavone-induced hepatocellular tumors in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Ah receptor antagonism inhibits constitutive and cytokine inducible IL6 production in head and neck tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Ah receptor antagonism represses head and neck tumor cell aggressive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Biology and function of the aryl hydrocarbon receptor: report of an international and interdisciplinary conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Treatments for chronic myeloid leukemia: a qualitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The selective aryl hydrocarbon receptor modulator 6-methyl-1,3,8-trichlorodibenzofuran inhibits prostate tumor metastasis in TRAMP mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

beta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Contributions of aryl hydrocarbon receptor genetic variants to the risk of glioma and PAH-DNA adducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Efficacy and safety of laquinimod in multiple sclerosis: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon exposure induces expression of MMP-9 in human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Lineage-dependent effects of aryl hydrocarbon receptor agonists contribute to liver tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Androgen receptor antagonists for prostate cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Gene expression changes in human prostate carcinoma cells exposed to genotoxic and nongenotoxic aryl hydrocarbon receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

A proposed mechanism for the protective effect of dioxin against breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

CXCR4 and CXCL12 down-regulation: a novel mechanism for the chemoprotection of 3,3'-diindolylmethane for breast and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Multiple mechanisms are involved in Ah receptor-mediated cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBN-induced urinary bladder carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Cross-talk between 2,3,7,8-tetrachlorodibenzo-p-dioxin and testosterone signal transduction pathways in LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

SERMs: meeting the promise of multifunctional medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

A century of deciphering the control mechanisms of sex steroid action in breast and prostate cancer: the origins of targeted therapy and chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

BRCA1 modulates xenobiotic stress-inducible gene expression by interacting with ARNT in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF/IL-1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Xeno-sensing activity of the aryl hydrocarbon receptor in human pluripotent stem cell-derived hepatocyte-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in experimental models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Anti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-β1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The dioxin/aryl hydrocarbon receptor mediates downregulation of osteopontin gene expression in a mouse model of gastric tumourigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Ahr null alleles: distinctive or different?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Retinoid receptors and therapeutic applications of RAR/RXR modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Cytochrome P4501A1 promotes G1 phase cell cycle progression by controlling aryl hydrocarbon receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin at a trichlorophenol plant in New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Cancer treatment and survivorship statistics, 2016.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

2,3,7,8-Tetrachlorodibenzo-p-dioxin has both pro-carcinogenic and anti-carcinogenic effects on neuroendocrine prostate carcinoma formation in TRAMP mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor-mediated inhibition of LNCaP prostate cancer cell growth and hormone-induced transactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor ligands in cancer: friend and foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor nuclear translocator in hepatocytes is required for aryl hydrocarbon receptor-mediated adaptive and toxic responses in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Identification of small molecules that support human leukemia stem cell activity ex vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Cancer incidence in the population exposed to dioxin after the "Seveso accident": twenty years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Related Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor-induced adrenomedullin mediates cigarette smoke carcinogenicity in humans and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Benzimidazoisoquinolines: a new class of rapidly metabolized aryl hydrocarbon receptor (AhR) ligands that induce AhR-dependent Tregs and prevent murine graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Biological and tumor-promoting effects of dioxin-like and non-dioxin-like polychlorinated biphenyls in mouse liver after single or combined treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor-dependent apoptotic cell death induced by the flavonoid chrysin in human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

2,3,7,8-Tetrachlorodibenzo-p-dioxin induces apoptosis in neural growth factor (NGF)-differentiated pheochromocytoma PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Taxonomy of breast cancer based on normal cell phenotype predicts outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The Alternaria mycotoxins alternariol and alternariol methyl ether induce cytochrome P450 1A1 and apoptosis in murine hepatoma cells dependent on the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Using nuclear receptor activity to stratify hepatocarcinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Overexpression of the aryl hydrocarbon receptor (AhR) accelerates the cell proliferation of A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

21 January 2018

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Treatment of mice with the Ah receptor agonist and human carcinogen dioxin results in altered numbers and function of hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Ligand promiscuity of aryl hydrocarbon receptor agonists and antagonists revealed by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Role for the Aryl Hydrocarbon Receptor and Diverse Ligands in Oral Squamous Cell Carcinoma Migration and Tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Non-canonical modulators of nuclear receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Insulin like growth factor 2 regulation of aryl hydrocarbon receptor in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Global Cancer Incidence and Mortality Rates and Trends--An Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Inhibition of constitutive aryl hydrocarbon receptor (AhR) signaling attenuates androgen independent signaling and growth in (C4-2) prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Curcumin Suppresses Phthalate-Induced Metastasis and the Proportion of Cancer Stem Cell (CSC)-like Cells via the Inhibition of AhR/ERK/SK1 Signaling in Hepatocellular Carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The current state of breast cancer classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

PPARalpha transcriptionally induces AhR expression in Caco-2, but represses AhR pro-inflammatory effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Ah-receptor-independent stimulation of hepatoma 27 culture cell proliferation by polycyclic aromatic hydrocarbons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor activation and overexpression upregulated fibroblast growth factor-9 in human lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor activation during pregnancy, and in adult nulliparous mice, delays the subsequent development of DMBA-induced mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Activation of the aryl hydrocarbon receptor by TCDD inhibits mammary tumor metastasis in a syngeneic mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Complementation of Ah receptor deficiency in hepatoma cells: negative feedback regulation and cell cycle control by the Ah receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

A selective aryl hydrocarbon receptor modulator 3,3'-Diindolylmethane inhibits gastric cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Downregulation of aryl hydrocarbon receptor expression decreases gastric cancer cell growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The AhR is involved in the regulation of LoVo cell proliferation through cell cycle-associated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Activation of aryl hydrocarbon receptor suppresses invasion of esophageal squamous cell carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Akt‑mediated phosphorylation of Oct4 is associated with the proliferation of stem‑like cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-017-1981-2

Novel target genes of the Ah (dioxin) receptor: transcriptional induction of N-myristoyltransferase 2

21 January 2018

1 reference

12 December 2020

Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis: constitutive activation of AhR in ATL

1 reference

12 December 2020

Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.

1 reference

12 December 2020

Gastric hamartomatous tumours in a transgenic mouse model expressing an activated dioxin/Ah receptor

1 reference

12 December 2020

Development of selective aryl hydrocarbon receptor modulators for treatment of breast cancer

1 reference

12 December 2020

Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro

1 reference

12 December 2020

Expression of aryl hydrocarbon receptor in relation to p53 status and clinicopathological parameters in breast cancer.

1 reference

12 December 2020

Hexachlorobenzene induces cell proliferation, and aryl hydrocarbon receptor expression (AhR) in rat liver preneoplastic foci, and in the human hepatoma cell line HepG2. AhR is a mediator of ERK1/2 signaling, and cell cycle regulation in HCB-treated

1 reference

12 December 2020

Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor

1 reference

12 December 2020

Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor

1 reference

12 December 2020

Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase

1 reference

12 December 2020

10.1007/S00204-017-1981-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28508231%20AND%20SRC:MED&resulttype=core&format=json

release_e4ek25num5eu5fhevcwuzc7kka

20 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e4ek25num5eu5fhevcwuzc7kka

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28508231%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

28508231

1 reference